CXCR4 as a Therapeutic Target in Acute Myeloid Leukemia

Investigators examine its molecular aspects influencing cancer progression, such as its impact on autonomous proliferation, apoptotic regulation, chemoresistance mechanisms, and interactions with non-leukemic cells such as MSCs and Treg cells.